Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Post PCI High Sensitivity Troponin Elevation: No Prognostic Value

Post PCI High Sensitivity Troponin Elevation

The prognostic value of high sensitivity troponin elevation after elective PCI in patients with or without elevated baseline values remains unclear.

 

The aim of this study was to measure the prognostic value of post elective procedure high sensitivity troponin and to determine whether this may be influenced by baselines TnT values.

 

The study included 5,626 patients undergoing coronary PCI with available baseline and post procedural TnT values. Primary end point 3 year mortality (estimating the risk by logarithmic increase of high sensitivity TnT value).

 

Patients were divided in four groups:

  • nonelevated baseline and post procedure high sensitivity TnT (TnT ≤0.014 μg/l; n = 742),
  • nonelevated baseline but elevated post procedure hs TnT values (pico post-procedimiento TnT >0.014 μg/l; n = 2,721),
  • elevated baseline values (TnT >0.014 μg/l) but with no post procedure elevation (n = 516),
  • elevated baseline values with even higher post procedure elevation (n = 1,647).

 

There were 265 deaths, 6 (2.3%) in patients with normal baseline and post procedural hs TnT, 54 (20.4%) in patients with normal baseline but elevated post procedural hs TnT, 50 (18.9%) in patients with elevated baseline hs TnT but no higher post procedural hs TnT, and 155 (58.5%) in patients with high sensitivity baseline and higher post procedural hs TnT (p<0.001).

 

After adjusting, elevated baseline values (HR 1.22; IC 95% 1.09 a 1.38; p < 0.001) were associated to mortality, but not the post procedure rise of hs TnT (HR 1.04; IC 95% 0.85 a 1.28; p=0.679).

 

Peak post procedural hs TnT was not associated with increased mortality in patients with normal baseline hs Tnt values (HR 0.93; IC 95% 0.69 a 1.25; p=0.653) or elevated baseline hs TnT values (HR 1.24; IC 95% 0.91 a 1.69; p=0.165).

 

Conclusion

In patients with heart disease undergoing programmed PCI, a rise in hs TnT values after procedure does not provide prognostic information beyond baseline TnT levels.

 

Editorial Comment

The definition of periprocedural MI used in clinical studies is more associated to events, as opposed to spontaneous MI.

 

Prior studies (Comparison of the Prognosis of Spontaneous and Percutaneous Coronary Intervention–Related Myocardial Infarction, Sergio Leonardi. JACC Vol. 60, No. 22, 2012) had already shown the benign evolution of periprocedural MI and the present study brings additional information in favor of this point.

 

Original Title: High-Sensitivity Troponin T and Mortality after Elective Percutaneous Coronary Intervention.

Reference: Gjin Ndrepepa et al. J Am Coll Cardiol. 2016;68(21):2259-2268.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...